Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Gustafson

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Natural Product Reports|December 22, 2020
Sesterterpenoids: chemistry, biology, and biosynthesisKeke Li, Kirk R Gustafson
International Journal of Cancer|April 22, 2003
Marine pharmacology in 2000: antitumor and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
Journal of Natural Products|August 31, 2004
Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritinaNicole Lopanik, Kirk R Gustafson, Niels Lindquist
European Journal of Cancer (Oxford, England : 1990)|August 12, 2006
Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Marine pharmacology in 2001-2: antitumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
European Journal of Cancer (Oxford, England : 1990)|August 15, 2008
Marine pharmacology in 2005-2006: antitumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
FEBS Letters|September 11, 2004
The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1Norelle L Daly, Kirk R Gustafson, David J Craik
Current Protein & Peptide Science|November 17, 2004
Anti-HIV cyclotidesKirk R Gustafson, Tawnya C McKee, Heidi R Bokesch
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporterKentaro Takada, Nobutaka Imamura, Kirk R Gustafson, et al.
Chemical & Pharmaceutical Bulletin|January 4, 2021
Four New Pregnane-10,2-carbolactones from an Epipolasis sp. Marine SpongeUnwoo Kang, Dongdong Wang, Heidi R Bokesch, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Natural Product Reports|December 22, 2020
Sesterterpenoids: chemistry, biology, and biosynthesisKeke Li, Kirk R Gustafson
International Journal of Cancer|April 22, 2003
Marine pharmacology in 2000: antitumor and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
Journal of Natural Products|August 31, 2004
Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritinaNicole Lopanik, Kirk R Gustafson, Niels Lindquist
European Journal of Cancer (Oxford, England : 1990)|August 12, 2006
Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Marine pharmacology in 2001-2: antitumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
European Journal of Cancer (Oxford, England : 1990)|August 15, 2008
Marine pharmacology in 2005-2006: antitumour and cytotoxic compoundsAlejandro M S Mayer, Kirk R Gustafson
FEBS Letters|September 11, 2004
The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1Norelle L Daly, Kirk R Gustafson, David J Craik
Current Protein & Peptide Science|November 17, 2004
Anti-HIV cyclotidesKirk R Gustafson, Tawnya C McKee, Heidi R Bokesch
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporterKentaro Takada, Nobutaka Imamura, Kirk R Gustafson, et al.
Chemical & Pharmaceutical Bulletin|January 4, 2021
Four New Pregnane-10,2-carbolactones from an Epipolasis sp. Marine SpongeUnwoo Kang, Dongdong Wang, Heidi R Bokesch, et al.
Pageof 10